Logo.png
Stereotaxis to Report Third Quarter 2020 Financial Results on November 9, 2020
26 oct. 2020 16h05 HE | Stereotaxis, Inc.
ST. LOUIS, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Logo.png
First Hospitals in the World Adopt Genesis Robotic Technology for Cardiac Heart Rhythm Disorders
14 sept. 2020 09h00 HE | Stereotaxis, Inc.
ST. LOUIS, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it has...
Logo.png
Stereotaxis CEO Invited to Speak on Plenary Panel at RAPS Convergence 2020
08 sept. 2020 09h05 HE | Stereotaxis, Inc.
ST. LOUIS, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Logo.png
Stereotaxis to Present at Three Investor Conferences in September
28 août 2020 09h05 HE | Stereotaxis, Inc.
ST. LOUIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Logo.png
Journal of American College of Cardiology Publishes Pioneering Study Using Stereotaxis Robotic Technology to Treat Pulmonary Hypertension
26 août 2020 09h05 HE | Stereotaxis, Inc.
ST. LOUIS, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a pioneering...
Logo.png
Stereotaxis Reports 2020 Second Quarter Financial Results
06 août 2020 09h00 HE | Stereotaxis, Inc.
ST. LOUIS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Logo.png
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
31 juil. 2020 08h05 HE | Stereotaxis, Inc.
ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote...
Logo.png
Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020
23 juil. 2020 16h05 HE | Stereotaxis, Inc.
ST. LOUIS, July 23, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Logo.png
Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication
13 juil. 2020 09h05 HE | Stereotaxis, Inc.
ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
Logo.png
Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes
22 juin 2020 09h05 HE | Stereotaxis, Inc.
ST. LOUIS, June 22, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the company...